Literature DB >> 5409801

Pathways of fatty acid metabolism in human platelets.

P Cohen, A Derksen, H Van den Bosch.   

Abstract

The metabolic fate of (14)C-labeled fatty acids which have been incubated with human platelets, has been traced. The following has been shown. (a) Intact platelets have a considerable capacity to oxidize fatty acids. (b) When tracer amounts of four of the most common fatty acids in normal plasma were incubated with platelets, each showed a distinctive pattern of uptake among neutral lipids and phospholipids. With regard to the latter, it was shown that these distribution patterns were, in most cases, similar to those of the fatty acids found in natural platelet phospholipids. (c) By increasing the time of incubation or the amount of added oleic acid, the distribution of oleic acid uptake between lecithin and other phosphoglycerides was altered so that a larger share was incorporated into the latter. (d) The effects of added lysolecithin or lysoethanolamine phosphoglycerides on oleic acid incorporation into platelet phosphoglycerides are quite variable. At low concentrations, added lysolecithin functions chiefly as a reaction partner for oleic acid. Added adenosine triphosphate and CoASH augment the incorporation of oleic acid into lecithin over a wide range of added lysolecithin (12.5-500 mumoles/liter). At higher concentrations of added lysolecithin, in the absence of ATP and CoASH, oleic acid incorporation into lecithin is considerably reduced. Also, added lysolecithin and lysoethanolamine phosphoglycerides, in the absence of ATP and CoASH, are able, at certain concentrations, to stimulate oleic acid incorporation into all except the serine phosphoglycerides. (e) Platelets appear to have a de novo pathway for renewal of lecithin.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5409801      PMCID: PMC322451          DOI: 10.1172/JCI106211

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Synthesis of saturated and unsaturated L-alpha-lecithins; acylation of the cadmium chloride compound of L-alpha-glycerylphosphorylcholine.

Authors:  E BAER; D BUCHNEA
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  METABOLISM OF PHOSPHOLIPIDS IN NORMAL AND SPHEROCYTIC HUMAN ERYTHROCYTES.

Authors:  A F ROBERTSON; W E LANDS
Journal:  J Lipid Res       Date:  1964-01       Impact factor: 5.922

3.  INCORPORATION OF FATTY ACIDS INTO PHOSPHOLIPIDS OF ERYTHROCYTE MEMBRANES.

Authors:  M M OLIVEIRA; M VAUGHAN
Journal:  J Lipid Res       Date:  1964-04       Impact factor: 5.922

4.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

5.  Absence of plasma transamidase activity in congenital deficiency of fibrin stabilizing factor (Factor 13).

Authors:  K Miloszewski; W D Walls; M S Losowsky
Journal:  Br J Haematol       Date:  1969-08       Impact factor: 6.998

6.  Metabolism of red-cell lipids. I. Incorporation in vitro of fatty acids into phospholipids from mature erythrocytes.

Authors:  E Mulder; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1965-07-07

7.  Characterization and quantification of red cell lipids in normal man.

Authors:  P Ways; D J Hanahan
Journal:  J Lipid Res       Date:  1964-07       Impact factor: 5.922

8.  The incorporation of acetate and palmitate into lipids by human platelets.

Authors:  D Deykin; R K Desser
Journal:  J Clin Invest       Date:  1968-07       Impact factor: 14.808

9.  Metabolism of glycerolipids. III. Reactivity of various acyl esters of coenzyme A with alpha'-acylglycerophosphorylcholine, and positional specificities in lecithin synthesis.

Authors:  W E LANDS; I MERKL
Journal:  J Biol Chem       Date:  1963-03       Impact factor: 5.157

10.  Factors affecting the hemolytic action of "lysolecithin" upon rabbit erythrocytes.

Authors:  H B COLLIER
Journal:  J Gen Physiol       Date:  1952-03       Impact factor: 4.086

View more
  14 in total

1.  Identical subcellular distribution of palmitoyl-CoA and arachidonoyl-CoA synthetase activities in human blood platelets.

Authors:  A M Bakken; M Farstad
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

Review 2.  Are phospholipases involved in platelet activation?

Authors:  G Bereziat
Journal:  Agents Actions       Date:  1979-10

3.  Metabolic tracing analysis reveals substrate-specific metabolic deficits in platelet storage lesion.

Authors:  Carrie Sims; Noelle Salliant; Andrew J Worth; Robert Parry; Clementina Mesaros; Ian A Blair; Nathaniel W Snyder
Journal:  Transfusion       Date:  2017-08-23       Impact factor: 3.157

4.  Effects of diets high in saturated fat and cholesterol on the lipid composition of canine platelets.

Authors:  R E Pitas; G J Nelson; R M Jaffe; R W Mahley
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

5.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

Authors:  T Eichholtz; K Jalink; I Fahrenfort; W H Moolenaar
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

6.  The effect of phospholipase C on human blood platelets.

Authors:  A B Otnaess; T Holm
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

7.  Altered lipid metabolism in human platelets after primary aggregation.

Authors:  D Deykin
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

8.  Increased fluidity of human platelet membranes during complement-mediated immune platelet injury.

Authors:  S J Shattil; D B Cines; A D Schreiber
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

9.  Dissecting the metabolic pathways controlling platelet survival in vivo: are our platelets what they eat?

Authors:  Shailaja Hegde; Jose A Cancelas
Journal:  Transfusion       Date:  2016-08       Impact factor: 3.157

10.  Quantification of human platelet inositides and the influence of ionic environment on their incorporation of orthophosphate-32P.

Authors:  P Cohen; M J Broekman; A Verkley; J W Lisman; A Derksen
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.